North America Active Pharmaceutical Ingredients (API) Market is projected to grow by 4.8% annually in the forecast period and reach $120.7 billion by 2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in the geriatric population. Highlighted with 82 tables and 75 figures, this 197-page report “North America Active Pharmaceutical Ingredients (API) Market 2022-2032...
Europe Active Pharmaceutical Ingredients (API) Market was valued at $ 49.4 billion in 2022 and will grow by 6.8% annually over 2022-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in the geriatric population. Highlighted with 91 tables and 76 figures, this 198-page report “Europe Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Larg...
Asia Pacific Active Pharmaceutical Ingredients (API) Market will grow by 8.1% annually with a total addressable market cap of $ 1,098.6 billion over 2023-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in the geriatric population. Highlighted with 88 tables and 75 figures, this 196-page report “Asia Pacific Active Pharmaceutical Ingredients (API) Market 2022-2...
Global Clinical Trials Market will reach $79,977.1 million by 2031, growing by 7.0% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence of chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 148 tables and 111 figures, this 241-page report “Global Clinical Trials...
North America Clinical Trials Market is projected to grow by 7.1% annually in the forecast period and reach $39,268.7 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence of chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 89 tables and 75 figures, this 178-page report â...
Europe Clinical Trials Market was valued at valued at $10,939.1 million in 2022 and will grow by 6.4% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 99 tables and 79 figures, this 186-page report “Europe...
Asia Pacific Clinical Trials Market will grow by 8.4% annually with a total addressable market cap of $97,110.8 million over 2023-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence of chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 99 tables and 79 figures, this 186-page report ...
Switzerland Clinical Trials Market is projected to grow by 6.8% annually in the forecast period and reach $824.5 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 80 tables and 70 figures, this 170-page report “Swi...
Global medical lasers market will reach $16,239.7 million by 2032, growing by 13.2% annually over 2022-2032, driven by the increasing number of cosmetic procedures, the rising preference for minimally invasive procedures, a growing prevalence of eye disorders, the growth of medical tourism, and the growing disposable income. Highlighted with 87 tables and 97 figures, this 185-page report “Global Medical Lasers Market 2022-2032 by Device Type (Solid State, Gas, Diode, Dye), Power (High, ...
North America medical lasers market is projected to grow by 12.6% annually in the forecast period and reach $6,346.5 million by 2032, driven by the increasing number of cosmetic procedures, the rising preference for minimally invasive procedures, a growing prevalence of eye disorders, the growth of medical tourism, and the growing disposable income. Highlighted with 68 tables and 61 figures, this 123-page report “North America Medical Lasers Market 2022-2032 by Device Type (Solid State,...
